MAPT and Alzheimer disease: In mouse models of AD, increasing adrenergic tone results in cognitive improvement and attenuation of beta-amyloid load, neuroinflammation, and tau pathology (Heneka et al., 2010; Coutellier et al., 2014; Ardestani et al., 2017).